297 related articles for article (PubMed ID: 23374005)
1. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
2. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
4. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
5. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
[TBL] [Abstract][Full Text] [Related]
6. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node biopsy in elderly breast cancer patients.
Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
[TBL] [Abstract][Full Text] [Related]
8. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma].
Berclaz G; Crazzolara AO; Altermatt HJ; Aebi S; Fey MF; Hänggi W; Dreher E
Schweiz Med Wochenschr; 1998 Oct; 128(44):1730-6. PubMed ID: 9846346
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
[TBL] [Abstract][Full Text] [Related]
11. The sentinel node in breast cancer--a multicenter validation study.
Krag D; Weaver D; Ashikaga T; Moffat F; Klimberg VS; Shriver C; Feldman S; Kusminsky R; Gadd M; Kuhn J; Harlow S; Beitsch P
N Engl J Med; 1998 Oct; 339(14):941-6. PubMed ID: 9753708
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases.
Menes TS; Tartter PI; Mizrachi H; Constantino J; Estabrook A; Smith SR
J Am Coll Surg; 2005 Mar; 200(3):323-7. PubMed ID: 15737841
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
15. Validation of Memorial Sloan Kettering Cancer Center nomogram to detect non-sentinel lymph node metastases in a United Kingdom cohort.
Syed A; Eleti S; Kumar V; Ahmad A; Thomas H
G Chir; 2018; 39(1):12-19. PubMed ID: 29549676
[TBL] [Abstract][Full Text] [Related]
16. Identification of sentinel node in breast cancer.
Zerwes FP; Frasson AL; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2002 Jun; 21(2):155-8. PubMed ID: 12148570
[TBL] [Abstract][Full Text] [Related]
17. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
Skarping I; Ellbrant J; Dihge L; Ohlsson M; Huss L; Bendahl PO; Rydén L
BMC Cancer; 2024 Jan; 24(1):86. PubMed ID: 38229058
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients.
Yang JH; Nam SJ; Lee TS; Lee HK; Jung SH; Kim BT
Jpn J Clin Oncol; 2001 Jan; 31(1):1-6. PubMed ID: 11256834
[TBL] [Abstract][Full Text] [Related]
19. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging.
Mussurakis S; Buckley DL; Horsman A
Radiology; 1997 May; 203(2):317-21. PubMed ID: 9114081
[TBL] [Abstract][Full Text] [Related]
20. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy.
Chung MA; Steinhoff MM; Cady B
Am J Surg; 2002 Oct; 184(4):310-4. PubMed ID: 12383890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
